☆ 4.4 Article

Children's Oncology Group's 2023 blueprint for research: Cellular therapy and stem cell transplantation

PEDIATRIC BLOOD & CANCER (2023)

Related references

Note: Only part of the references are listed.

Article Hematology

Applications of virus-specific T cell therapies post-BMT

Cecilia M. Motta et al.

Summary: Hematopoietic stem cell transplantation (HSCT) has been used as a standard treatment for primary immunodeficiency disorders and relapsed hematologic malignancies for over 50 years. However, viral infections after HSCT remain a significant cause of morbidity and mortality, and current antiviral therapies are limited by toxicity and emerging resistance. Adoptive immunotherapy using virus-specific T cells (VSTs) has shown promising results in previous studies, providing safe and effective treatment or prevention of viral infections with minimal side effects and low risk of graft vs host disease. This review summarizes the methods to generate VSTs, the clinical outcomes of VST therapeutics, and the challenges and future directions in this field.

SEMINARS IN HEMATOLOGY (2023)

Add to Collection

Article Hematology

Effective treatment of low-risk acute GVHD with itacitinib monotherapy

Aaron Etra et al.

Summary: The standard treatment for acute graft-versus-host disease (GVHD) involves high-dose corticosteroids, which can delay immune system recovery. However, a study found that itacitinib, a selective JAK1 inhibitor, may be a safe and effective alternative for low-risk GVHD patients. This drug showed higher response rates and a lower risk of infection compared to corticosteroids.

BLOOD (2023)

Add to Collection

Article Pediatrics

Prospective Evaluation of the Fungitell® (1→3) Beta-D-Glucan Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from the Children's Oncology Group

William R. Otto et al.

Summary: Fungitell (R) BDG screening is not effective in diagnosing IFD in the post-HCT period, mainly due to high false-positive rates. Fungitell (R) BDG surveillance testing should not be performed in children during the early post-HCT period while receiving antifungal prophylaxis.

PEDIATRIC TRANSPLANTATION (2023)

Add to Collection

Article Hematology

Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALL

Swati Naik et al.

Summary: Infusion of donor-derived multiple leukemia antigen-specific T cells may prevent disease relapse in patients with acute lymphoblastic leukemia (ALL) by targeting leukemia cells and minimizing the risk of graft-versus-host disease.

BLOOD (2022)

Add to Collection

Article Oncology

Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report

Liora M. Schultz et al.

Summary: Commercial tisagenlecleucel demonstrates efficacy and tolerability in patients with relapsed and refractory B-ALL. The study finds that high disease burden is associated with inferior overall survival, event-free survival, and increased toxicity.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Betibeglogene Autotemcel Gene Therapy for Non-β0/β0 Genotype β-Thalassemia

Franco Locatelli et al.

Summary: The study demonstrates that betibeglogene autotemcel therapy can achieve transfusion independence in patients with transfusion-dependent beta-thalassemia, with good safety profile and stable results, suitable for most patients with non-beta(0)/beta(0) genotype.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Hematology

CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR

Haneen Shalabi et al.

Summary: This study investigated the CAR T-cell therapy for B-cell malignancies and found that CD19.22.BB zeta showed good safety and efficacy. Further optimization of combinatorial antigen targeting can overcome certain limitations.

BLOOD (2022)

Add to Collection

Article Oncology

Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031

Jessica A. Pollard et al.

Summary: The study investigated the feasibility and efficacy of adding sorafenib, a multikinase tyrosine kinase inhibitor, to standard chemotherapy and as single-agent maintenance therapy in pediatric acute myeloid leukemia (AML) with high allelic ratio (HAR) FLT3/ITD mutations. The results showed that sorafenib can be safely added to conventional AML chemotherapy and may improve outcomes in this population. Patients treated with sorafenib had higher survival rates and disease-free survival rates compared to those who did not receive sorafenib.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Review Oncology

CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy

Ezgi Elmas et al.

Summary: This review discusses the applications and feasibility of CRISPR/Cas9 gene editing and engineering strategies for cancer immunotherapy, as well as several approaches to study CRISPR off-target effects.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Hematology

Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT

Hannah Kinoshita et al.

Summary: This study evaluated the safety and clinical outcomes of a novel T-cell therapy targeting tumor-associated antigens in patients with relapsed acute leukemia after allogeneic bone marrow transplantation. The therapy showed promising results with sustained remissions in high-risk and relapsed patients, and no severe side effects were observed.

BLOOD ADVANCES (2022)

Add to Collection

Letter Hematology

αβT- and B-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation in children with myelodysplastic syndromes

Pietro Merli et al.

HAEMATOLOGICA (2022)

Add to Collection

Article Hematology

Monitoring Neurocognitive Functioning After Pediatric Cellular Therapy or Hematopoietic Cell Transplant: Guidelines From the COG Neurocognition in Cellular Therapies Task Force

Hannah-Lise T. Schofield et al.

TRANSPLANTATION AND CELLULAR THERAPY (2022)

Add to Collection

Article Oncology

Chlorhexidine gluconate bathing in children with cancer or those undergoing hematopoietic stem cell transplantation: A double-blinded randomized controlled trial from the Children's Oncology Group

Danielle M. Zerr et al.

Summary: The study found that daily bathing with CHG-impregnated cloths did not reduce CLABSI in pediatric oncology patients and those undergoing HCT. There was a higher rate of CLABSI in the CHG group compared to the control group, while the rates of total positive blood cultures and acquisition of resistant organisms did not differ significantly between the two groups.

CANCER (2021)

Add to Collection

Article Oncology

Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study

Christina Peters et al.

Summary: The study compared the efficacy of preparative combination chemotherapy with total body irradiation in pediatric patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation. Improved overall survival and lower risk of relapse were observed with total body irradiation plus etoposide compared to chemoconditioning, leading to a recommendation for total body irradiation plus etoposide in these patients.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

H. Frangoul et al.

Summary: Research utilizing CRISPR-Cas9 technology for gene editing in patients with TDT and SCD showed high levels of edited alleles in bone marrow and blood, leading to partial or complete elimination of symptoms.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Cell Biology

The role of the intestinal microbiota in allogeneic HCT: clinical associations and preclinical mechanisms

Chi L. Nguyen et al.

Summary: The intestinal microbiota plays a key role in allo-HCT outcomes, affecting factors such as infection, immune reconstitution, GVHD, and relapse. Further research is needed to fully understand this relationship.

CURRENT OPINION IN GENETICS & DEVELOPMENT (2021)

Add to Collection

Article Medicine, General & Internal

Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia A Randomized Clinical Trial

Patrick A. Brown et al.

Summary: In children, adolescents, and young adults with high- and intermediate-risk first relapse of B-ALL, postreinduction treatment with blinatumomab compared with chemotherapy, followed by transplant, did not result in a statistically significant difference in disease-free survival. However, study interpretation is limited by early termination with possible underpowering for the primary end point.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Infectious Diseases

A Randomized Trial of Caspofungin vs Triazoles Prophylaxis for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplant

Christopher C. Dvorak et al.

Summary: This study showed that prophylaxis with caspofungin did not significantly reduce the cumulative incidence of early proven or probable invasive fungal disease (IFD) compared with triazoles in pediatric patients undergoing hematopoietic cell transplantation. Future efforts should focus on reducing the morbidity and mortality related to IFD.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2021)

Add to Collection

Article Hematology

Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1

M. Meaghan Granger et al.

Summary: BuMel ASCT following COG induction for high-risk neuroblastoma in children is well tolerated, with low rates of toxicity during consolidation and no deaths during this period. The 3-year event-free survival and overall survival rates are favorable for eligible patients.

TRANSPLANTATION AND CELLULAR THERAPY (2021)

Add to Collection

Article Oncology

Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333

Alyssa T. Reddy et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Article Hematology

Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults

Heather J. Symons et al.

BLOOD ADVANCES (2020)

Add to Collection

Review Chemistry, Analytical

A Systematic Review of Machine Learning Techniques in Hematopoietic Stem Cell Transplantation (HSCT)

Vibhuti Gupta et al.

SENSORS (2020)

Add to Collection

Article Oncology

Immunotherapy of Relapsed and Refractory Solid Tumors With Ex Vivo Expanded Multi-Tumor Associated Antigen Specific Cytotoxic T Lymphocytes: A Phase I Study

Amy B. Hont et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

Add to Collection

Article Medicine, General & Internal

Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma A Randomized Clinical Trial

Julie R. Park et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Add to Collection

Article Hematology

Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children

Jennifer S. Whangbo et al.

BLOOD ADVANCES (2019)

Add to Collection

Article Hematology

More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling

Peter Bader et al.

BLOOD ADVANCES (2019)

Add to Collection

Article Hematology

Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis

Muna Qayed et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)

Add to Collection

Article Medicine, General & Internal

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

S. L. Maude et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Oncology

Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study

Christopher C. Dvorak et al.

PEDIATRIC BLOOD & CANCER (2018)

Add to Collection

Article Medicine, General & Internal

Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation A Randomized Clinical Trial

Sarah Alexander et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Add to Collection

Article Medicine, General & Internal

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

F. M. Marty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection

Review Multidisciplinary Sciences

Systematic Review of the Toxicity of LongCourse Oral Corticosteroids in Children

Fahad Aljebab et al.

PLOS ONE (2017)

Add to Collection

Article Biophysics

Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?

M. A. Pulsipher et al.

BONE MARROW TRANSPLANTATION (2015)

Add to Collection

Article Medicine, General & Internal

One-Unit versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers

John E. Wagner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Add to Collection

Article Medicine, General & Internal

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

Shannon L. Maude et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Add to Collection

Article Medicine, General & Internal

HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the US Registry

Loren Gragert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Add to Collection

Article Biophysics

A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1

A. E. Seif et al.

BONE MARROW TRANSPLANTATION (2013)

Add to Collection

Article Hematology

Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for Subacute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation

Gregory A. Yanik et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)

Add to Collection

Article Medicine, General & Internal

Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

John Koreth et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Add to Collection

Article Oncology

Impact of Disease Risk on Efficacy of Matched Related Bone Marrow Transplantation for Pediatric Acute Myeloid Leukemia: The Children's Oncology Group

John T. Horan et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Add to Collection

Article Hematology

Umbilical Cord Blood Transplantation in adults: Results of the prospective Cord Blood Transplantation (COBLT)

K Cornetta et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)

Add to Collection

Article Biophysics

Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia:: A Pediatric Blood and Marrow Transplant Consortium study

N Bunin et al.

BONE MARROW TRANSPLANTATION (2003)

Add to Collection

Article Multidisciplinary Sciences

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

L Ruggeri et al.

SCIENCE (2002)

Add to Collection

Article Oncology

Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma

SA Grupp et al.

JOURNAL OF CLINICAL ONCOLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.